Anne Bouvier

6PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematologyPredictive and prognostic markersCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2024
Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study.

Corentin Orvain, Sarah Bertoli, Pierre Peterlin

|Apr 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.

Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann

|Sep 15, 2021
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study.

Raynier Devillier, Edouard Forcade, Alice Garnier

|Mar 25, 2021
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.

Anne Bouvier, Jean-François Hamel, Jacques Delaunay

|Nov 27, 2019
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation.

Anne Bouvier, Jérémie Riou, Sylvain Thépot

|Jul 15, 2018
Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.

Anne Bouvier, Bénédicte Ribourtout, Sylvie François

Pageof 1

Frequent Collaborators

3 joint publications

Christian Récher

2 joint publications

Mathilde Hunault-Berger

2 joint publications

Eric Delabesse

1 joint publications

Corentin Orvain